Business Context and Reporting Period
This Form 8-K is a current report filed by iSpecimen Inc. (ISPC) on January 5, 2026, regarding events occurring on December 31, 2025. The filing addresses the outcome of the Company's 2025 Annual Meeting of Stockholders.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses solely on corporate governance events and does not contain financial performance data.
Material Changes
The primary material event reported is the adjournment of the 2025 Annual Meeting of Stockholders held on December 31, 2025. The meeting was adjourned because a quorum was not achieved. The Company intends to reconvene the meeting on January 23, 2026, to allow additional time for stockholders to vote on the proposals outlined in the definitive proxy statement filed on November 21, 2025. The record date for the meeting remains November 3, 2025.
Guidance, Outlook, and Risks
The filing does not contain financial guidance, management commentary on business outlook, or specific risk factors beyond the procedural delay in the Annual Meeting. The reconvened meeting is scheduled to address the same proposals as originally intended.
Key Facts for Investor Verification
- The 2025 Annual Meeting was adjourned due to a lack of quorum.
- The meeting is rescheduled for January 23, 2026.
- The record date for voting eligibility remains November 3, 2025.
- Investors should review the definitive proxy statement filed on November 21, 2025, for details on the pending proposals.